Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

Ascend Aegis has retired technical risk (94% accuracy) and mitigated market risk (MedSleep partnership). With infrastructure costs deferred through our Nuvollo partnership, this pre-seed round is a pure deployment and regulatory sprint to own the sleep diagnostic market.
In modern sleep medicine, data collection has outpaced human analysis. Millions of hours of PSG data are generated annually, but the industry remains tethered to manual scoring.
We have solved the "Holy Grail" of automated sleep diagnostics.
Achieved 94% average staging accuracy (Wake-N1-N2-N3-REM) using our proprietary Transformer-based architecture.
Validated by MedSleep Inc. (Canada’s largest network) with a $25k MVP payment and an MOU for 40,000 annual studies.

Clinical Validation: Side-by-side hypnogram comparison showing the near-identical alignment between manual human scoring (MedSleep) and Aegis AI automated staging.
Acquisition #02602506-110978
100% Capital Velocity. While other AI startups burn seed funding on server costs, Aegis is subsidized for growth.
The Nuvollo Partnership Through a strategic alliance with Nuvollo, Aegis has secured a private, high-performance cloud environment on a deferred payment schedule for a full year (starting Jan 1, 2026).
Impact: Your investment goes directly into commercialization, regulatory filings, and clinic acquisitions, not infrastructure bills.
Our pre-seed capital is weaponized for three specific, high-value milestones:
Executive Summary: Why This Pair? The path to FDA and Health Canada licensing for a sleep diagnostic tool typically fails at one of two hurdles: Clinical Inaccuracy or Production Fragility.
The Matrix of Expertise:
Frank Tabuco: The Accuracy Engine
Lester Lagrimas: The Production Backbone
Proven Execution Within Aegis
This is not a theoretical partnership; the duo is already executing on the following core infrastructure:
The "Moat": Defensibility Through Peer Review
Unlike many startups, the Aegis engineering team leads with defensible, community-visible science. By pairing a Medical-AI Specialist with a Systems Architect, Ascend Aegis eliminates the "Research-to-Production" gap that plagues most healthcare startups. This duo ensures the Aegis Sleep Diagnostic Tool is built to be licensed, built to be trusted, and built to scale..
Ascend Aegis is an AI-driven medical company transitioning from a software tool to a comprehensive healthcare operating system. The "Deconstructing the Pitch" video outlines their strategy to build a market monopoly through three core pillars:
Ascend Aegis is revolutionizing the healthcare landscape by developing a comprehensive diagnostic operating system. This video explores the company's strategic vision to:
Ascend Aegis Corporation
95 Mural Street, Richmond Hill, Ontario, Canada L4B 3G2
Copyright © 2026 Ascend Aegis Corporation. All Rights Reserved.
Powered by Nuvollo Cloud
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.